These findings indicate that the combined effects of EPAC1 insufficiency and EPAC2A overactivation disrupt the balance of the EPAC-leptin axis, ultimately contributing to the development of obesity. Here, RAPGEF4 is linked to obesity due to melanocortin 4 receptor deficiency.